Circulation, Vol 82, 1802-1814, Copyright © 1990 by American Heart Association
RS Beanlands, F Dawood, WH Wen, PR McLaughlin, J Butany, G D'Amati and PP Liu
To investigate the role of cell viability and metabolism on the myocardial
kinetics of a new tracer, technetium-99m-methoxyisobutyl isonitrile
(Tc-99m-MIBI), 250 microCi/l Tc-99m-MIBI was infused in isolated rat hearts
under constant flow conditions. The hearts were studied after inducing
irreversible damage by cytochrome c oxidase inhibitor sodium cyanide (n =
8) or sarcolemmal membrane detergent Triton X-100 (n = 8). The control
hearts (n = 6) received no toxins. Mean Tc-99m-MIBI peak accumulation
activity was significantly reduced after cyanide (51.1 +/- 44.2% of
control, p less than 0.01) and Triton (13.8 +/- 2.7% of control, p less
than 0.001) administration. Kinetic studies also showed marked reduction in
accumulation rates and marked increase in clearance rates for cyanide (p
less than 0.01) and Triton (p less than 0.01) groups compared with
controls. Potential changes in regional flow distribution were assessed
using microspheres. When peak accumulation activity was corrected for these
changes, there remained significant differences between the groups. In the
cyanide and Triton groups, irreversible cell injury was confirmed by
creatine kinase and lactate dehydrogenase release, triphenyl tetrazolium
chloride staining, and electron microscopy. All the cells were viable in
the control group. We conclude that the accumulation and clearance kinetics
of Tc- 99m-MIBI are significantly affected by cell viability. Tc-99m-MIBI
kinetics appear to be dependent on sarcolemmal integrity and to a lesser
extent on aerobic metabolism.
ARTICLES
Are the kinetics of technetium-99m methoxyisobutyl isonitrile affected by cell metabolism and viability?
Nuclear Cardiology Laboratory, Toronto Hospital, Canada.
This article has been cited by other articles:
![]() |
R. Sciagra Nitrates and Viability: A Durable Affair J. Nucl. Med., May 1, 2003; 44(5): 752 - 755. [Full Text] [PDF] |
||||
![]() |
F. C. Visser Prediction of Surgical Treatment Effect by Preoperative Imaging:Present and Future Perspectives Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2003; 7(1): 31 - 36. [PDF] |
||||
![]() |
H. A. Dakik, J. F. Howell, G. M. Lawrie, R. Espada, D. G. Weilbaecher, Z.-X. He, J. J. Mahmarian, and M. S. Verani Assessment of Myocardial Viability With 99mTc-Sestamibi Tomography Before Coronary Bypass Graft Surgery : Correlation With Histopathology and Postoperative Improvement in Cardiac Function Circulation, November 4, 1997; 96(9): 2892 - 2898. [Abstract] [Full Text] |
||||
![]() |
R. Medrano, R. W. Lowry, J. B. Young, D. G. Weilbaecher, L. H. Michael, I. Afridi, Z.-X. He, J. J. Mahmarian, and M. S. Verani Assessment of Myocardial Viability With 99mTc Sestamibi in Patients Undergoing Cardiac Transplantation: A Scintigraphic/Pathological Study Circulation, September 1, 1996; 94(5): 1010 - 1017. [Abstract] [Full Text] |
||||
![]() |
V. Sansoy, D. K. Glover, D. D. Watson, M. Ruiz, W. H. Smith, J. P. Simanis, and G. A. Beller Comparison of Thallium-201 Resting Redistribution With Technetium-99m–Sestamibi Uptake and Functional Response to Dobutamine for Assessment of Myocardial Viability Circulation, August 15, 1995; 92(4): 994 - 1004. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1990 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |